172 filings
Page 3 of 9
8-K
5fc7 j71nxawdegla7i
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
c99by6u4vieh93
11 May 22
Trevena Reports First Quarter 2022 Results and Provides
7:05am
8-K
v83ss8 od
25 Apr 22
Other Events
7:01am
8-K
l0dcok2xz
20 Apr 22
Regulation FD Disclosure
5:11pm
8-K
8gpdqrdutf
20 Apr 22
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
8:59am
8-K
9dt6 v0y32zy2
31 Mar 22
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing
7:05am
8-K
94jkant6edaoe2ef
31 Mar 22
Trevena Reports Fourth Quarter and Full Year 2021 Results
7:04am
8-K
14ea4c2
27 Jan 22
Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical
9:04am
8-K
ieswkovcfpewa
23 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
u05xynlbvs3jxz
15 Nov 21
Trevena Reports Third Quarter 2021 Results
9:24pm
8-K
4ops5a8jr d9
4 Oct 21
Other Events
6:02am
8-K
nl2qi
7 Sep 21
Other Events
4:05pm
8-K
bg4oq4hgd2
12 Aug 21
Trevena Reports Second Quarter 2021 Results
8:02am
8-K
e9efjn
4 Aug 21
Other Events
4:04pm
8-K
lc6bhhyj9cp4 jdayho
16 Jun 21
Regulation FD Disclosure
4:08pm
8-K
0uu mk7zy8l3
28 May 21
Other Events
5:23pm
8-K
cutmi7r
14 May 21
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
u8x3dc
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
c60rq76tnwksgco
21 Apr 21
Regulation FD Disclosure
7:05am
8-K
a64uk cldt1c
18 Mar 21
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
7:01am